Patents by Inventor Qiang Feng

Qiang Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11033614
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: June 15, 2021
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • Publication number: 20210170009
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 10, 2021
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • Publication number: 20210161964
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 3, 2021
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • Patent number: 10894065
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: January 19, 2021
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • Patent number: 10883146
    Abstract: Biomarkers and methods for predicting risk of a disease in particular RA are provided. Sequences of DNA are obtained. The DNA may be extracted from a sample that is collected from a subject. A relative abundance of a biomarker is then calculated based on the sequences of the DNA. The biomarker comprises a DNA sequence in a genome of Lactobacillus salivarius. A probability of the subject having the disease is obtained based on the relative abundance.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: January 5, 2021
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Dongya Zhang, Huijue Jia, Donghui Wang, Jun Wang
  • Patent number: 10809363
    Abstract: An anti-interference ranging method and an anti-interference ranging apparatus are provided. The method includes: detecting, by a first light detection and ranging device, whether a light detection process is interfered by a second light detection and ranging device in the ranging system; delaying, by the first light detection and ranging device, the light detection process for a preset time period if it is detected that the light detection process is interfered by the second light detection and ranging device; and acquiring, by the first light detection and ranging device, detection data collected in the light detection process, and processing, by the first light detection and ranging device, the detection data to obtain a ranging result if it is detected that the light detection process is not interfered by the second light detection and ranging device.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: October 20, 2020
    Assignee: BENEWAKE (BEIJING) CO., LTD.
    Inventors: Qiang Feng, Suo Lu, Xuxing Li, Lun Wo, Ying Zhang, Hao Liu, Qingshun Zhang, Kai Zheng, Da Shu, Yuan Li
  • Patent number: 10693731
    Abstract: A flow entry management method comprises receiving a management instruction for any flow entry, where the management instruction is initiated by a controller connected to a switch, wherein the switch may first determine, according to an obtained management authority level of the the controller relative to the switch and a security level of the any flow entry, when the management authority level of the any controller relative to the the switch is not lower than the security level of the a flow entry corresponding to the management instruction initiated by the any controller, that the controller has an authority to perform corresponding management on the any flow entry, and perform corresponding management on the any flow entry according to the management instruction initiated by the controller.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: June 23, 2020
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Jianyao Liang, Qiang Feng
  • Publication number: 20200181864
    Abstract: The present disclosure provides an effective stress cell for direct measurement of effective stress in saturated soil. The effective stress cell comprises a sensing diaphragm, a porous diaphragm, a connector and a strain sensor. The porous diaphragm allows pore-water to enter the interior space between the sensing diaphragm and the porous diaphragm to provide complete balance of pore-water pressures in the front and back of the sensing diaphragm. Thus, the effective stress cell can directly and accurately measure the effective stress in saturated soil using only one diaphragm at one location without measuring pore-water pressure.
    Type: Application
    Filed: November 20, 2019
    Publication date: June 11, 2020
    Inventors: Jian-Hua YIN, Jie-Qiong QIN, Wei-Qiang FENG
  • Publication number: 20200023011
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Application
    Filed: August 1, 2019
    Publication date: January 23, 2020
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • Patent number: 10541914
    Abstract: A data packet forwarding method and a network device, where the method includes, receiving a data packet, obtaining a local physical address and a destination physical address of the data packet when the entry matching the data packet does not exist in the first match table, determining whether the local physical address is the same as the destination physical address, searching a second match table for an entry in which a physical address matches the destination physical address when the local physical address is different from the destination physical address, generating a layer 2 forwarding entry according to the entry matching the destination physical address, and forwarding the data packet according to the layer 2 forwarding entry. Therefore, processing efficiency of the new data packet and network performance are improved.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: January 21, 2020
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Qiang Feng, Jianyao Liang, Huibin Luo
  • Patent number: 10526659
    Abstract: Biomarkers and methods related to microbiota for predicting the risk of a disease, particularly colorectal cancer (CRC), are described.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: January 7, 2020
    Assignees: BGI Shenzhen Co., Limited, BGI Shenzhen
    Inventors: Qiang Feng, Dongya Zhang, Longqing Tang, Jun Wang
  • Publication number: 20190367995
    Abstract: Biomarkers and methods for predicting the risk of a disease related to microbiota, in particular colorectal cancer (CRC), are described.
    Type: Application
    Filed: August 15, 2019
    Publication date: December 5, 2019
    Inventors: Qiang FENG, Dongya ZHANG, Youwen QIN
  • Patent number: 10494661
    Abstract: Disclosed are a stabilizer for storage of a biological sample, a composition for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions, a kit comprising the composition, a mixture comprising the composition and a biological sample, and a method for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions. The integrity and stability of the nucleic acid and/or polypeptide in a biological sample can be stored for a long time under non-freezing conditions by using the stabilizer according to the invention, and therefore the stabilizer has a good application prospect.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: December 3, 2019
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Mo Han, Liang Xiao, Jun Wang
  • Publication number: 20190359709
    Abstract: Disclosed is a pharmaceutical preparation comprising a CD147 monoclonal antibody, a buffer, a protein protectant and a surfactant. The pharmaceutical preparation can maintain the stability of the CD147 monoclonal antibody over a long period of time. Also disclosed are the use of the pharmaceutical preparation in the preparation of a drug for treating CD147-related diseases, in particular non-small cell lung cancer, and a method for preparing the pharmaceutical preparation.
    Type: Application
    Filed: December 27, 2017
    Publication date: November 28, 2019
    Inventors: Hao TANG, Qiang FENG, Xiaochun CHEN
  • Patent number: 10461986
    Abstract: A data transmission method in software-defined networking (SDN) environment using transmission control protocol (TCP). An application server sends a transmission resource allocation request to a controller. The request carries an address of a sending device and an address of a receiving device. The controller determines a first transmission path and a second transmission path between the sending device and the receiving device according to the request. The first transmission path is used by the sending device to transmit data to the receiving device, and the second transmission path is used by the receiving device to transmit an acknowledgment to the sending device. The controller sends a transmission resource allocation response to the application server. The application server determines, according to the response, an initial value of a transmit window for transmitting data. The sending device transmits the data to the receiving device according to the transmit window.
    Type: Grant
    Filed: September 10, 2017
    Date of Patent: October 29, 2019
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Fengwei Zhang, Weifeng Shen, Qiang Feng
  • Patent number: 10426799
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Grant
    Filed: December 21, 2013
    Date of Patent: October 1, 2019
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • Publication number: 20190162830
    Abstract: An anti-interference ranging method and an anti-interference ranging apparatus are provided. The method includes: detecting, by a first light detection and ranging device, whether a light detection process is interfered by a second light detection and ranging device in the ranging system; delaying, by the first light detection and ranging device, the light detection process for a preset time period if it is detected that the light detection process is interfered by the second light detection and ranging device; and acquiring, by the first light detection and ranging device, detection data collected in the light detection process, and processing, by the first light detection and ranging device, the detection data to obtain a ranging result if it is detected that the light detection process is not interfered by the second light detection and ranging device.
    Type: Application
    Filed: November 30, 2017
    Publication date: May 30, 2019
    Applicant: Benewake (Beijing) Co., Ltd.
    Inventors: Qiang FENG, Suo LU, Xuxing LI, Lun WO, Ying ZHANG, Hao LIU, Qingshun ZHANG, Kai ZHENG, Da SHU, Yuan LI
  • Patent number: 10230647
    Abstract: A data packet processing method, Where the method includes matching a received data packet in a flow table, and determining the received data packet as a newly-established data packet, where the newly-established data packet is a data packet that needs to be reported to a controller to determine a processing manner, determining a target priority of the newly-established data packet, and reporting the newly-established data packet to the controller according to the target priority. Priorities of data packets entering an OPENFLOW switch are determined, and for unsuccessfully matched data packets, a data packet having a high priority is forwarded preferentially according to the priorities, thereby ensuring that data having a high priority is not discarded.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: March 12, 2019
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Qiang Feng, Huan Zhang, Jiang Tan
  • Publication number: 20180340225
    Abstract: An intestinal microorganism metagenomic feature is a bacteroid intestinal pattern. By using the intestinal metagenomic pattern, it was found that type 2 diabetic patients with different intestinal parasitic bacterial flora had remarkably different responses to treatment with the diabetic hypoglycemic drug acarbose. Therefore, before treatments, the intestinal patterns of the patients can be assessed to select those patients likely to experience optimal curative effects, and to determine whether acarbose is suitable for the treatment of individual patients with type 2 diabetes. In addition, while intestinal patterns are conventionally distinguished by DNA sequencing or PCT amplification of parasitic bacteria in excrements, the intestinal patterns can be well distinguished using a bile acid composition, especially secondary bile acids, under baseline conditions. The intestinal patterns can be identified through markers in blood, and then be used as markers for diagnosis.
    Type: Application
    Filed: December 16, 2015
    Publication date: November 29, 2018
    Applicants: SHANGHAI INSTITUTE FOR ENDOCRINE AND METABOLIC DISEASES, BGI Shenzhen
    Inventors: Guang NING, Dongya ZHANG, Weiqing WANG, Xiaokai WANG, Yanyun GU, Qiang FENG, Ruixin LIU, Xiaoqiang XU, Huahui REN, Huanzi ZHONG
  • Publication number: 20180339034
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Application
    Filed: March 21, 2016
    Publication date: November 29, 2018
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li